Inventiva (IVA) Set to Announce Quarterly Earnings on Wednesday

Inventiva (NASDAQ:IVA) is set to announce its quarterly earnings results before the market opens on Wednesday, September 25th. Analysts expect the company to announce earnings of ($0.50) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Inventiva Stock Performance

Shares of IVA stock opened at $2.19 on Tuesday. Inventiva has a 1 year low of $2.05 and a 1 year high of $4.75. The stock’s 50 day simple moving average is $2.29 and its two-hundred day simple moving average is $3.01.

Inventiva Company Profile

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI.